Rating Unavailable
There isn't enough annual-report data to calculate a rating.
2026 · Year to Date | 994 € | - | 0 € | 5 | - |
|---|---|---|---|---|---|
2026 Q3 | 994 € | - | 0 € | 5 | 10,552 € |
Name | Born | Roles | |
|---|---|---|---|
- | Board Member · Shareholder 33.33% · Beneficial Owner · Founder | ||
- | Board Member · Shareholder 33.33% · Beneficial Owner · Founder | ||
- | Shareholder 33.33% | ||
- | Founder |
Name | Born | Nationality | Registered | |
|---|---|---|---|---|
- | - | |||
- | - |
Name | Registered | Until |
|---|---|---|
- | ||
- | ||
- |
Name | Born | Position | Registered | |
|---|---|---|---|---|
- | ||||
- |
Name | Born | Roles | Until |
|---|---|---|---|
- | Beneficial Owner |
Category | Scope | Number | Status | Expiry |
|---|---|---|---|---|
Food Establishment | Food Establishment Registration · Toitlustamine | 307144 | Valid | - |
Activity Notice | KTO025680 | Valid | - |
Share capital 2,700 €. Beneficial owners: Aleksei Novikov, Toni Jegorov.